Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?

Immunotherapy has changed the treatment paradigm in multiple solid and hematologic malignancies. However, response remains limited in a significant number of cases, with tumors developing innate or acquired resistance to checkpoint inhibition. Certain “hot” or “immune-sensitive” tumors become “cold”...

Descripción completa

Detalles Bibliográficos
Autores principales: El Sayed, Rola, Haibe, Yolla, Amhaz, Ghid, Bouferraa, Youssef, Shamseddine, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927105/
https://www.ncbi.nlm.nih.gov/pubmed/33670011
http://dx.doi.org/10.3390/ijms22042142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927105/
https://www.ncbi.nlm.nih.gov/pubmed/33670011
http://dx.doi.org/10.3390/ijms22042142

Ejemplares similares